These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27404031)

  • 21. Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study.
    Cagnacci A; Malmusi S; Arangino S; Zanni A; Rovati L; Cagnacci P; Volpe A
    Menopause; 2002; 9(1):65-71. PubMed ID: 11791088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease.
    Jhund PS; Dawson N; Davie AP; Sattar N; Norrie J; O'Kane KP; McMurray JJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1367-73. PubMed ID: 11300448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
    Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
    Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
    Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
    Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
    Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
    Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
    Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
    Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
    Brüll V; Burak C; Stoffel-Wagner B; Wolffram S; Nickenig G; Müller C; Langguth P; Alteheld B; Fimmers R; Naaf S; Zimmermann BF; Stehle P; Egert S
    Br J Nutr; 2015 Oct; 114(8):1263-77. PubMed ID: 26328470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin C improves endothelial function in healthy estrogen-deficient postmenopausal women.
    McSorley PT; Young IS; Bell PM; Fee JP; McCance DR
    Climacteric; 2003 Sep; 6(3):238-47. PubMed ID: 14567772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy improves cardiovascular risk by lowering plasma viscosity in postmenopausal women.
    Rosenson RS; Tangney CC; Mosca LJ
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1902-5. PubMed ID: 9848882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
    Harman SM; Black DM; Naftolin F; Brinton EA; Budoff MJ; Cedars MI; Hopkins PN; Lobo RA; Manson JE; Merriam GR; Miller VM; Neal-Perry G; Santoro N; Taylor HS; Vittinghoff E; Yan M; Hodis HN
    Ann Intern Med; 2014 Aug; 161(4):249-60. PubMed ID: 25069991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement.
    Kublickiene K; Fu XD; Svedas E; Landgren BM; Genazzani AR; Simoncini T
    J Clin Endocrinol Metab; 2008 May; 93(5):1874-83. PubMed ID: 18319309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early postmenopausal women with cardiovascular risk factors improve microvascular dysfunction after acute estradiol administration.
    Clapauch R; Mecenas AS; Maranhão PA; Bouskela E
    Menopause; 2012 Jun; 19(6):672-9. PubMed ID: 22314638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.
    Vitale C; Mammi C; Gambacciani M; Russo N; Spoletini I; Fini M; Volterrani M; Rosano GMC
    Int J Cardiol; 2017 Jan; 227():217-221. PubMed ID: 27843051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.